Please use this identifier to cite or link to this item:
|Title:||First Two Years' Response to Growth Hormone Treatment in Very Young Preterm Small for Gestational Age Children|
|Authors:||Garcia, R. A. M.|
Longui, C. A.
Faria, C. D. C.
Calliari, L. E. P.
Pachi, P. R.
Universidade Federal de São Paulo (UNIFESP)
Albert Einstein Coll Med
Small for gestational age
|Citation:||Hormone Research. Basel: Karger, v. 72, n. 5, p. 275-280, 2009.|
|Abstract:||Background: Growth hormone (GH) is a therapeutic option for small for gestational age (SGA) children without spontaneous catch-up. There are few reports on preterm SGA children. Prematurity is an additional risk factor for adult short stature. Aim: To describe GH efficacy in preterm SGA patients. Methods: Twenty-five preterm SGA patients, 2-4 years old, treated with GH 0.066 mg/kg/day, were compared with 14 age-matched preterm SGA historical controls. Height, weight, IGF-I, IGFBP-3, fasting glucose and insulin were measured every 6 months. Results: At start of GH treatment, mean height and weight were -2.4 and -2.4 SDS, respectively. There was a significant increment in height SDS of 1.3 and 2.1 during the 1st and the 2nd year of GH therapy, respectively. There was no significant difference between the progression of chronological and bone ages. A significant increase in IGF-I, IGFBP-3 and molar ratio was observed during GH therapy. There was no difference in glucose, insulin or HOMA-IR index. Conclusion: We showed for the first time that the height increment of preterm SGA with GH treatment is similar to that described in other studies with term SGA patients. Therefore, short-term GH treatment in a subset of preterm SGA patients between 2-4 years of age was able to promote adequate growth recovery with no excessive bone age acceleration or adverse effects on carbohydrate metabolism. Copyright (C) 2009 S. Karger AG, Basel|
|Appears in Collections:||Em verificação - Geral|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.